Ultrasound imaging for the rheumatologist XXIX. Sonographic assessment of the knee in patients with osteoarthritis by Iagnocco, Annamaria et al.
643
Imaging
Ultrasound imaging for the rheumatologist 
XXIX. Sonographic assessment of the knee in patients 
with osteoarthritis 
 
 A. Iagnocco1, G. Meenagh2, L. Riente3, E. Filippucci4, A. Delle Sedie3, C.A. Scirè5, 
F. Ceccarelli1, C. Montecucco5, W. Grassi4, S. Bombardieri3, G. Valesini1
1Cattedra di Reumatologia, Dipartimento 
di Medicina Interna e Specialità Mediche, 
Sapienza Università di Roma, Roma, Italy; 
2Department of Rheumatology, Antrim 
Hospital, Antrim, United Kingdom;
3Unità Operativa di Reumatologia, 
Università di Pisa, Pisa, Italy; 
4Cattedra di Reumatologia, Università 
Politecnica delle Marche, Ancona, Italy; 
5Cattedra di Reumatologia, IRCCS 






Andrea Delle Sedie, MD
Carlo Alberto Scirè, MD
Fulvia Ceccarelli, MD
Carlomaurizio Montecucco, MD, Prof.        
Walter Grassi, MD, Professor
Stefano Bombardieri, MD, Prof.
Guido Valesini, MD, Prof.
Please address correspondence to: 
Annamaria Iagnocco, 
UOC Reumatologia, 
Dipartimento di Medicina Interna 
e Specialità Mediche, 
Sapienza Università di Roma, 
Viale del Policlinico 155, 
00161, Roma, Italy.
E-mail: annamaria.iagnocco@uniroma1.it
Received and accepted on October 8, 
2010.
Clin Exp Rheumatol 2010; 28: 643-646.
© Copyright CLINICAL AND 
EXPERIMENTAL RHEUMATOLOGY 2010.
Key words: Ultrasound, knee,
osteoarthritis
Competing interests: none declared.
ABSTRACT
Objective. To investigate the preva-
lence and severity of sonographic-de-
tected abnormalities in knee osteoar-
thritis (OA) and to correlate ultrasound 
(US) findings with clinical data.
Methods. Outpatients with chronic, 
painful knee OA according to the ACR 
criteria were consecutively recruited 
and underwent clinical and US exami-
nations. An expert rheumatologist re-
corded the presence of knee joint pain, 
swelling and tenderness, patient’s glo-
bal assessment of knee pain using visu-
al analogue scale (VAS), and Lequesne 
Index of severity for knee OA. A second 
rheumatologist, blinded to the clinical 
data, performed the knee US examina-
tion using a Logiq9 machine equipped 
with a 12MHz linear probe and reg-
istering the presence of joint effusion, 
synovial proliferation, power Doppler 
(PD) signal, Baker’s cyst, osteophytes 
and femoral cartilage abnormalities.
Results. One hundred and sixty-four 
knees of 82 patients (53 women, 29 
men) were studied; mean age was 63.2 
±8.1 SD years, mean disease duration 
was 4.3±5.6 SD years. All patients 
complained of at least one knee joint 
pain during physical activity. Mean pa-
tient’s VAS for knee pain was 48.4±19.9 
SD mm, mean Lequesne Index was 8.2 
±4.4 SD. Knee swelling was present in 
39% of the patients and tenderness was 
found in 65.8%. US showed: joint effu-
sion in 43.3% of the patients, synovial 
proliferation in 22.1%, PD signal in 
2.9%, Baker’s cysts in 6.6%, cartilage 
abnormalities in 79%, osteophytes in 
100%. In all patients US findings were 
present at least at the level of one knee. 
Statistically significant correlations 
were demonstrated between a com-
posite inflammatory score and both 
VAS (p=0.004) and Lequesne Index 
(p<0.0001).
Conclusions. This US study showed 
both inflammatory abnormalities and 
structural damage lesions in knee OA. 
Interestingly, statistically significant cor-
relations were demonstrated between US 
inflammatory findings and the main clini-
cal tests for OA, confirming that sonog-
raphy has a relevant role in the global 
evaluation of patients with knee OA.
Introduction 
Osteoarthritis (OA) is the most com-
mon rheumatic disease and the most 
frequent cause of rheumatic com-
plaints, thus determining a relevant 
public health problem (1). It is a chron-
ic disorder characterised by a series of 
abnormalities which involve the whole 
joint organ with progressive cartilage 
abnormalities and associated bone and 
soft tissues changes. The main patho-
logical findings are represented by 
dysregulation of local turnover with 
modifications in repairing processes 
that lead to progressive degeneration 
and loss of cartilage, and thickening of 
the subchondral bone, joint margin and 
capsule (1, 2). Episodic, non-destruc-
tive and non-aggressive synovitis often 
occurs and usually contributes to the 
presence and worsening of symptoms 
and cartilage deterioration. In those 
cases, synovial proliferation, joint effu-
sion and bursitis are frequently present. 
Usually, OA appears and progressively 
worsens with age progression, thus 
having a great social impact, especially 
in the aging population of industrial-
ised countries (3). The involvement of 
the knee joint leads to a severe disease 
phenotype, with evidence of disability 
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and work impairment that frequently 
appear prematurely. This is due to joint 
use-related pain, swelling, stiffness, 
deformity, reduction of muscle strength 
and limited joint motion (1, 2).
Musculoskeletal ultrasound (US) rep-
resents a new imaging modality, which 
has been increasingly utilised in rheu-
matology during recent years. Thanks 
to progressive technical advances and 
technological developments, US has 
markedly increased its ability to im-
age different anatomic structures and 
their abnormalities in the finest details 
(1, 4-8). In last few years, most of the 
interest in the field of US has focussed 
on inflammatory arthritis and soft tissue 
disorders and, to date, it has been used 
for the evaluation of OA less frequently 
(1, 9-12).
The aims of this study were to inves-
tigate the prevalence and severity of 
sonographic-detected abnormalities in 
knee OA by using US, and to correlate 
US-detected findings with clinical and 
laboratory data.
Methods
This was a cross sectional, multicentre 
Italian study conducted in 4 rheumatol-
ogy units. The study was performed ac-
cording to the Declaration of Helsinki 
and local regulations, and informed 
consent was obtained from all patients.
Patients
Outpatients with chronic, painful knee 
OA were consecutively recruited and 
underwent clinical and US examina-
tions within a maximum of 4 hours 
time interval. A single rheumatologist 
performed the clinical evaluation and 
patients were subsequently assessed by 
a different rheumatologist, experienced 
in musculoskeletal US, who performed 
the sonographic examination and was 
unaware of the clinical results. Data 
were recorded by the investigators on 
2 separate case report forms and after-
wards evaluated for statistical analysis. 
The main inclusion criteria were men 
or women over 18 years of age with 
primary knee joint OA according to 
the American College of Rheumatol-
ogy (13); with first OA symptoms ap-
pearing at least 6 months before; with 
radiographic signs of OA defined as by 
Kellegren and Lawrence (14); and with 
a pain intensity during physical activ-
ity in the previous week >20mm on a 
100mm visual analogue scale (VAS) 
(15). 
Exclusion criteria were a history of in-
jury to the knees in the 6 months before 
the study entry; knee joint surgery, in-
cluding arthroscopy; knee intra-articu-
lar injections given during the previous 
3 months before the start of the study; 
and evidence of any other rheumatic 
diseases.
Clinical evaluation
The clinical parameters collected were 
demographic data, time duration since 
symptoms onset, knee joint pain, knee 
joint swelling, knee joint tenderness, 
patient’s global assessment of knee pain 
using a 100mm VAS, and Lequesne In-
dex of severity for knee OA (16). 
Ultrasound
US examination of both knees was per-
formed in all patients by using a Logiq 
9 (General Electric Medical Systems, 
Milwaukee, WI) equipped with a mul-
ti-frequency linear probe, working at 
12MHz. Power Doppler (PD) was used 
for assessing synovial vascularity (PRF 
500Hz, Doppler frequency 7.5MHz and 
Doppler gain at the level that avoided 
random noise visualisation). Exami-
nations were carried out following in-
ternational guidelines (17). Synovial 
hypertrophy and synovial fluid were de-
fined according to Outcome Measures 
in Rheumatoid Arthritis Clinical Tri-
als (OMERACT) definitions (18), and 
scored following a semi-quantitative 4 
points scale (0 = normal; 1 = mild; 2 
= moderate; 3 = severe). Synovial per-
fusion detected by PD was also scored 
according to a semi-quantitative, from 
0 to 3, grading system (0 = absence 
of flow; 1 = mild: up to 3 single spots 
signals or up to 2 confluent spots or 1 
confluent spot + up to 2 single spots; 2 
= moderate: vessel signals in <50% of 
the area of the synovium (but more than 
grade 1); 3 = marked: vessel signals in 
>50% of the area of the synovium). The 
presence or absence of a Baker’s cyst, 
defined as an abnormal hypo-anechoic, 
displaceable and compressible material 
within the gastrocnemius-semimem-
branosus bursa, was indicated respec-
tively with a score of 1 or 0. In each 
patient, the sum of these scores (range 
0–10), was used as an indicator of glo-
bal inflammatory changes at single knee 
joint level; in each patient, a composite 
inflammatory score (total US score), de-
rived by summing the single joint scores 
obtained at both knees, was used as an 
indicator of total knee joints inflamma-
tory involvement (range 0–20) (19).
Moreover, the presence/absence of 
osteophytes and abnormalities of the 
femoral cartilage were registered. Os-
teophytes were defined as cortical pro-
trusions at the joint margin seen in two 
planes and visualised as either proximal 
or distal to the joint. Hyaline cartilage 
abnormalities were defined as either the 
loss of cartilage anechoic echostructure, 
the loss of its sharpness of at least one 
margin, the presence of irregularities of 
margins or the thinning of the layer. 
Statistical analysis
The statistical analysis was performed 
with Statistical Package for Social Sci-
ences software 13.0 (SPSS 13.0, Chi-
cago, Illinois, USA). The correlations 
were performed with the Spearman test. 
All p-values were two-tailed, and p≤0.05 
were considered to be significant.
Results
Demographic, clinical and US findings 
are summarised in Table I. 
Patient characteristics and 
clinical findings
One hundred and sixty-four knees of 
82 osteoarthritis patients were studied; 
women/men ratio was 1.82 (53/29), 
mean age was 63.2±8.1 SD years and 
mean time duration since symptoms 
onset was 4.3±5.6 SD years. 
All patients were receiving either an-
algesic or non-steroidal-anti-inflamma-
tory drugs and complained of at least 
one knee joint pain during physical 
activity. 
Mean patient’s VAS for knee pain was 
48.4±19.9 SD mm and mean Lequesne 
Index was 8.2±4.4 SD. 
Knee swelling was present in 39% of 
the patients (29.6% of the joints); knee 
tenderness was found in 65.8% of the 
patients (47.6% of the joints).




US showed the presence of joint effu-
sion in 43.3% of patients, the signs of 
synovial proliferation in 22.1%, the ev-
idence of increased vascularisation by 
PD in 2.9% and the finding of a Bak-
er’s cyst in 6.6% (Fig. 1). The mean 
total US score was 2.87±2.8 SD. 
Cartilage abnormalities were detected 
in 79% of patients and osteophytes 
were found in 100% of cases (Fig. 1).
In all patients US findings were present 
at least at the level of one knee.
Statistically significant correlations 
were demonstrated between total US 
score and VAS (p=0.004) as well as 
between total US score and Lequesne 
Index (p<0.0001) (Fig. 2).
Discussion
This study demonstrated the presence 
of inflammatory abnormalities as well 
as of structural damage lesions in pa-
tients with painful, knee OA. A high 
prevalence of inflamed joints was 
present, particularly regarding the find-
ings of joint effusion and synovial pro-
liferation. These results, if compared 
to the rare prevalence of intra-articular 
PD signal, can probably only be par-
tially explained with the presence of 
a low inflammatory activity in our pa-
tients. In fact, the decreased sensitivity 
of sonographic equipment in the detec-
tion of flow at the level of deep joint 
sites needs to be taken into account 
when analysing this particular finding. 
This phenomenon is, in fact, very well 
known in the literature and has been 
demonstrated also at the level of other 
large joints (20, 21). US showed also 
a high prevalence of structural damage 
lesions both at the level of the femoral 
cartilage and, particularly, at the bony 
cortex level, where the total of the ex-
amined joints showed the presence of 
osteophytes. This typical and character-
istic finding of OA detected by US con-
firms the high sensitivity of this tool in 
the assessment of structural damage le-
sions (22). The statistically significant 
correlations between total US score and 
VAS, but also between total US score 
and Lequesne Index, confirm the im-
portance of the ultrasonographic find-
ings in the global assessment of patients 
with knee OA. US is, in fact, an imag-
ing modality which can be performed at 
bedside, immediately after the clinical 
examination, and is very well accepted 
by patients. The fact that US findings 
correlate with the main clinical tests for 
OA is a relevant result that needs to be 
taken into account when assessing the 
osteoarthritic patients. 
The role of US in the evaluation of OA 
has been recently underlined but, to 
date, only few investigators have con-
centrated on this topic (1, 22, 23).In par-
ticular, while there is clear evidence of 
the validity of US in detecting synovitis 
and structural abnormalities in inflam-
matory arthritis, more work is required 
to demonstrate the validity of this tool 
in OA (24). The knee is frequently 
involved in this disease and US has 
demonstrated to be a valuable imaging 
tool for the assessment of joint involve-
ment in this joint (25, 26). Similarly to 
other research conducted at the level 
of the hand, the present study showed 
synovitis changes as well as the typi-
cal structural lesions characterised by 
cartilage and bony cortex abnormalities 
(23). US is a valuable tool for imaging 
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Table I. Demographic, clinical and ultrasonographic findings. 
Number of patients     82
Number of knees 164
Gender: Female/Male (ratio) 53/29 (1.82)
Age: mean ± SD, years 63.2 ± 8.1
Time since symptoms onset: mean ± SD, years  4.3 ± 5.6
VAS pain: mean ± SD, mm  48.4 ± 19.9
Lequesne Index : mean ± SD 8.2 ± 4.4
Swollen joints: number of patients* (%) 32 (39)
Swollen joints: number of joints (%) 48 (29.6) 
Tender joints: number of patients* (%) 54 (65.8)
Tender joints: number of joints (%) 78 (47.6)
 
Ultrasonographic evaluation 
Synovial effusion : number of patients* (%) 35 (43.3)
Synovial effusion : number of joints (%) 60 (36.6)
Synovial proliferation: number of patients* (%) 18 (22.1)
Synovial proliferation: number of joints (%) 30 (18.3)
Power Doppler signal: number of patients* (%) 2 (2.9) 
Power Doppler signal: number of joints (%) 3 (1.8)
Baker cyst’s: number of patients* (%) 5 (6.6)
Baker cyst’s: number of joints (%) 5 (2.7)
Total US score : mean ± SD  2.87 ± 2.8
Cartilage abnormalities: number of patients* (%) 64 (79)
Cartilage abnormalities: number of joints (%) 124 (75.6)
Osteophytes: number of patients* (%) 82 (100)
Osteophytes: number of joints (%) 164 (100)
*Patients presented with US involvement of either one or both knees.
VAS: visual analogue scale; US: ultrasound.
Fig. 1. Grey-scale sonographic findings in knee osteoarthritis. (a) Anterior para-patellar longitudinal 
scan showing the presence of local effusion (*) and synovial proliferation (o). (b) Anterior supra-pa-
tellar transverse scan showing the femoral hyaline cartilage (arrowhead) abnormalities with evidence 
of loss of cartilage anechoic echostructure, loss of margins sharpness, irregularities of margins and 
thinning of the layer. (c) Longitudinal scan at the level of the medial aspect of the knee joint showing 
the presence of large osteophytes (arrows) visualised both proximal (femoral side) and distal (tibial 
side) to the joint.
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musculoskeletal changes in OA: it is a 
safe and widespread available imaging 
modality that can be used at bedside, 
during the global assessment of the pa-
tient with OA. The relatively low cost, 
short duration of single examinations 
and the possibility of performing a mul-
tiregional joint evaluation in the same 
scanning session further increases its 
clinical usefulness in the daily practise 
permitting an extensive evaluation of 
most joint changes present in patients 
with OA (1). 
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Fig. 2. Correlation be-
tween Total US score 
and VAS pain (A, 
p=0.004) and Lequesne 
Index (B, p<0.0001). 
VAS: visual analogue 
scale; US: ultrasound.
